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Skin testing with the suspected drugs may be helpful in
determining the cause of a cutaneous adverse reaction
(CADR). Tetrazepam (T) is a muscle relaxant of the ben-
zodiazepine group frequently used in rheumatology in
association with anti-inflammatory drugs (AIDs). We
propose to determine the usefulness of patch testing in
this context. Patients and methods A retrospective study
was conducted including all patients referred between
2000 and 2010 for patch testing after a CADR occurring
after concomitant administration of T and AIDs. Patch
test were performed at least 6 weeks after healing with T
and AIDs diluted at 10 % in petrolatum in a commercial
form (Chemotechnique Laboratory Diagnostics, Malmö,
Sweden) or crushed and diluted in petroleum. All
patients were contacted by letter in 2010 and data con-
cerning T or AID rechallenge, after the patch testing,
were collected. T patch testing was also performed on 10
controls, ie individuals who already took T but did not
present any CADR.
Results
15 subjects with a past history of CADR were referred for
patch testing with both T and AIDs possible / probable
culprit drugs. Among this patients, CADR included Ste-
vens Johnson/toxic epidermal necrolysis (5), maculopapu-
lar rash (7), Drug Reaction with Eosinophilia and Systemic
Symptoms (1) and Acute Generalized Exanthematous Pus-
tulosis (2). AIDs included ketoprofene (3), diclofenac (2),
rofecoxib (2), piroxicam (5), naproxène (1), prednisone (1),
cortivazol (1). Patch tests were positive for T and negative
for AIDs in 80 % of cases (12). Both patch tests were
negative in 20% (3). All the 10 control subjects had
negative patch test to T. Nine subjects answered to our
letter, none of them has been rechallenged with either T
or AIDs, whatever the results of the tests. Comments Posi-
tive T patch tests were obtained in 80% of cases whatever
the CARDs. This was much higher than the usual 30-50%
rate observed in the literature with miscellaneous drugs.
All the T exposed control subjects were negative as were
100 non exposed controls reported in literature. However,
its predictive value can not be determined in absence of
rechallenge after negative patch test. T CADR may be sys-
tematically suspected even in case of concomitant AIDs
intake. Readministration of AID could be allowed in non
severe CADR with negative AID patch testing and positive
one for T.
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